
--- Page 1 ---
/c Procedure Date: Circinoms mf1nting duct, Nos 85os/3 Procedure Physician: Attending Physician/Copies To: S.t Brust nus c5o.9.- M UUID:098BAFB4-94D0-4FC8-B938-D8A4108D8FC1 TCGA-BH-A1FE-01A-PR Redacted Patient history: + DATE OF LP: DATE OF LAST DRLIVERY: PRE-OP DIAGNOSIS: LEFT BREAST CA POST-OP DIAGNOSIS: SAME OPERATIVE PROCEDURE: LEET MOD RAD MAST AND AX DISS CLINICAL HISTORY:  MATERIAL SUBMITTED: A) :LEFT.-BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE B) LEFT AXILLARY LYMPH NODE(S), PROCUREMENT BY SURGICAL PROCEDURE) FINAL DIAGNOSIS: A) LEFT BREAST: - MULTIFOCAL' INFILTRATING DUCT CARCINOMA> POOR NUCLEAR AND HISTOLOGIC GRADE WITH CANCERIZATICN OF LOBULES, 3-5 BY 2.5 BY 1.S"CM, LARGEST FOCUS, OTHER FOCI MICROSCOPIC MICROCALCIFICATIONSS ANGIOLYMPHATIC INVASION IDENTIFIED - ALL MARGINS OF RESECTION NEGATIVE FOR INVASIVE TUMOR, BUT DUCTAL CARCINCMA IN SITU INVOLVES DEEP AND SUPERIOR MARGINS - NIPPLE AND SKIN UNINVOLVED BY TUMOR B) LEFT AXILLARY LYMPH NODES: ONE OF TWELVE (1/12) LYMPH NODES, POSITIVE FOR ADENOCARCINOMA (1/12)) NOTe: ER/pR immunoperoxidase assay and Her-2/Neu testing will be performed on block A3. SUPPLEMENTALREPORT (ER/PR) My signature below is attestation that I have reviewed all slides and agree with the findings as noted. below. IMMUNOPEROXIDASE IDENTIFICATION OF ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE A3. NO DISTINCT INTRANOCLEAR STAINING IS IDENTIFIED FOR EITHER RECEPTOR. THEREFORE, BOTH ARE INTERPRETED AS SUPPLEMENTALREPORT (HER-2/NEU) My sagnature below is attestation that I have reviewed all slides and agree with the findings as noted below. C-erbB2 (HER-2/NEU) IMMUNOSTAINING IS CARRIED OUT ON BLOCK A3 (BREAST CANCER) USING A 1:3O0 DILUTION OF DAKO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE INTRACELLULAR DCMAIN OF C-erbB2) WITHOUT ANTIGEN RETRIEVAL. NO DISTINCT COMPLETE MEMBRANE STAINING IS IDENTIFIED. THEREFORE, C-erbB2 (HER-2/NEU) IS INTERPRETED AS NEGATIVE.